Prostate Cancer
Surgical castration in hormone-refractory metastatic prostate cancer patients can be an alternative for medical castration - Abstract
August 1, 2011
The use of estramustine phosphate in the modern management of advanced prostate cancer - Abstract
August 1, 2011
Oncological and functional outcomes following open radical prostatectomy: How patients may achieve the ″trifecta″? - Abstract
August 1, 2011
Biochemical recurrence after radical prostatectomy: Is the disease or the surgeon to blame? - Abstract
August 1, 2011
Prostate cancer diagnostics: Innovative imaging in case of multiple negative biopsies - Abstract
July 29, 2011
No association of type-2 diabetes risk variants and prostate cancer risk: The Multiethnic Cohort and PAGE - Abstract
July 29, 2011
Prostatic disease and sexual dysfunction - Abstract
July 29, 2011
Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients - Abstract
July 29, 2011
Radiotherapy and short-term androgen deprivation for localized prostate cancer - Abstract
July 29, 2011
The association of diagnosis in the private or NHS sector on prostate cancer stage and treatment - Abstract
July 28, 2011
Emerging treatment options for patients with castration-resistant prostate cancer - Abstract
July 28, 2011
ASTRO publishes white paper on IMRT safety
July 28, 2011